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We report a case of a 29-year-old Marfan patient who developed prosthetic graft infection 10 months after Bentall
operation and successive replacement of the remaining ascending aorta and the entire aortic arch for acute aortic
dissection. Instead of an aggressive high-risk aortic redo procedure with removal and replacement of the infected
prosthetic graft we elected a staged graft-sparing surgical approach. After 18 months of close follow-up the patient
is in good condition and free from infectious sequela. This case and our review of the literature suggest that open
extensive disinfection followed by tissue flap coverage is highly effective in controlling thoracic aortic prosthetic
graft infection and may be considered as first-line treatment in such high-risk aortic arch redo patients.
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There is no consensus on proper surgical management
for prosthetic graft infection in patients who have had
an operation for reconstruction of ascending aorta and
aortic arch. Historically, a more aggressive but high-risk
aortic redo procedure with removal and replacement of
the infected prosthetic graft has been proposed by indi-
vidual surgeons in order to control this condition, with
unsatisfactory results (Coselli et al. 1990; Coselli et al.
1999). However, this type of surgery cannot be performed
in all patients. In recent years, an increasing body of pub-
lished evidence suggests that a more conservative, nonre-
sectional, graft-sparing surgical strategy with open surgical
disinfection followed by omentum flap coverage of the in-
fected ascending and arch prosthetic graft is gaining wider
acceptance as a more feasible and more effective treat-
ment therapy with excellent immediate and midterm out-
comes (Coselli et al. 1990; Coselli et al. 1999; Hargrove
and Edmunds 1984; Nakajima et al. 1999; LeMaire and
Coselli 2007). This case report contributes the ongoing
discussion on this important topic and may help to pay* Correspondence: ptossios@hotmail.com
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treatment strategies, and also thus avoid in selected pa-
tients unnecessary high-risk aortic redo procedures for
infected ascending and arch prosthetic grafts.Case description
A 29-year-old man with Marfan syndrome was referred
for assessment of a huge mediastinal fluid collection as-
sociated with an aortic prosthetic graft. At age 20 years,
he had undergone Bentall procedure with a short-cut
composite graft (Carbomedics Inc., Austin, TX) for acute
aortic dissection type A. Eight years later, he had a succes-
sive replacement of ascending aorta and the entire aortic
arch with a 24-mm Dacron graft (Gelweave, Vascutek Ltd,
Renfrewshire, Scotland), again for acute aortic dissection
involving the remaining aorta Surgery was performed
under moderate hypothermic circulatory arrest with se-
lective antegrade cerebral perfusion. The repair was ac-
complished by ligation of the left subclavian artery and
extranatomic reconstruction with an aorto-subclavian by-
pass by placing an 8-mm vascular Dacron graft. The pa-
tient was extubated at the first postoperative day (POD),
and subsequently was transferred to the ward. Intra- and
peri-operative antibiotic prophylaxis consisted by cipro-
floxacin and daptomycin as the patient had known drugan Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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patient was discharged home on POD 12. He was well
and fit until ten months later. At that moment he pre-
sented to his local hospital with hyperexia (39.5°C), sweats,
and chills. Routine laboratory investigations revealed a
leukocytosis of 19 × 109 cells/L. The patient was started
on intravenous rifampin and daptomycin. Multi-slice
computed tomographic (CT) aortography of his chest
demonstrated evidence of a huge fluid collection
surrounding both the ascending and aortic arch pros-
thetic grafts. Transthoracic echocardiography and sub-
sequent transesophageal echocardiography confirmed
the above findings. No prosthetic valve malfunction or
valvular vegetation was found and the blood cultures
were negative. Five days after his initial presentation,
the patient was transferred to our institution for further
care. The patient was afebrile and hemodynamically
stable. Upon patient’s physical examination no surgical
site infection was present. Chest roentgenogram revealed
a soft infiltration of the left lower lobe. Repeat CT angiog-
raphy was performed the next day to definitively evaluate
the integrity of anastomotic sites. There was no evidence
of anastomotic leak or false aneurysm formation. The col-
lection had a diameter of 15 cm with a density not exceed-
ing 20 Hounsfield Units strongly suggestive of prosthetic
graft infection (Figure 1 A-B). The patient underwent sub-
sequently fine-needle aspiration of purulent fluid under
CT guidance which confirmed the clinical diagnosis of
prosthetic graft infection that needed to be treated. Two
hours after the intervention, the patient was brought to
the operating room and the median sternotomy incisionFigure 1 Multi-slice computed tomography (CT) of the chest. Preopera
A) the ascending, and B) aortic arch prosthetic grafts having a diameter of
shows omental wrapping with normal density (65-80 Hounsfield Units) aro
evidence of fluid collection or infectious sequela 18 months after the operawas reopened. Surgical exploration of the mediastinum
demonstrated a considerable amount of purulent fluid
with which the ascending/arch prosthetic graft was
flooded. Suction of turbid effusion was followed by mod-
erate debridement of necrotic, infected tissues around the
prosthetic graft. Suture lines were intact but exposed
within the contaminated field. The aortic root, however,
was entirely covered with healthy autogenous tissue and
thus not exposed to pus. In the initial step, the mediastinal
cavity, especially around the graft, was thoroughly irri-
gated and washed initially with 3 liters of diluted, 1% iod-
ine solution, and then with 1 liter of saline solution
containing 1 g vancomycin. Thereafter, sponges soaked
with undiluted, 10% iodine solution were packed around
the contaminated graft as well as in the surrounding op-
erative field. The patient was returned to intensive care
unit (ICU) with the chest left open but covered by aseptic
drape. The same procedure of irrigation and packing of
the mediastinum was repeated every 8 hours for a 48 hour
period in the ICU, while the patient was maintained intu-
bated and sedated. The patient was brought back to the
operating room for the second operative step 48 hours
later. The omentum was harvested via a short upper ab-
dominal midline incision, separately from the previous
sternotomy wound, and transferred as a vascularized ped-
icle into the mediastinal cavity in order to wrap around
the ascending and arch prosthetic graft and anastomotic
sites with omentum completely (Figure 2). The chest was
closed in layers without placement of chest tubes or irri-
gation catheters. The patient had no operative compli-
cations, completed four weeks of intravenous colistin,tive CT shows a huge mediastinal fluid collection surrounding both
15 cm with a low density (12-18 Hounsfield Units). Postoperative CT
und the C) the ascending, and D) aortic arch prosthetic grafts without
tion.
Figure 2 Intraoperative photograph. A pedicle of omentum is brought up into chest to fill the mediastinal cavity and to surround the exposed
prosthetic graft.
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after discharged home in good condition on a regimen
of orally administered moxifloxacin. Cultures of serial
blood samples as well as specimens obtained both dir-
ectly from the infection site under CT guidance and in-
traoperatively from the perigraft pus collection were
negative throughout the course of treatment. The pa-
tient remains well without evidence of infectious se-
quela 18 months after the operation (Figure 1 C-D).
Discussion
Although prosthetic graft infections after ascending and/
or arch surgery are very rare (<3%), surgeons should re-
main cognizant of them because of the potential morbid-
ity and mortality complication (Coselli et al. 1990). There
are no surgical guidelines, and treatment of ascending and
arch prosthetic graft infection is still challenging (Teebken
et al. 2012). Traditionally, many authors believe that re-
moval and in situ replacement of all the prosthetic mater-
ial with a new one is mandatory. However, surgical
mortality and morbidity are still a major concern with
traditional replacement due to the invasiveness and com-
plexity of the procedure, emergency conditions, contami-
nated field, and the difficulties of exposure in the redo
aortic setting (Czerny et al. 2011). Two recent explants
studies from dedicated aortic centers, to our knowledge
the largest published series, have reported a hospital mor-
tality which ranges from 24% to 27% (Coselli et al. 1999;
Khaladj et al. 2013). These have been reports of small
series, including 11 patients from Texas and 17 patients
from Hanover in which redo ascending aortic replacement
and/or aortic arch replacement were performed by using
Dacron grafts or homografts without recurrences. The
leading cause of mortality was multiple organ failure fol-
lowing sepsis or profound bleeding (Coselli et al. 1999;
Khaladj et al. 2013). Successful redo in-situ replacement
surgery in this series was even among early survivors asso-
ciated with severe postoperative complications such aswound infection, respiratory failure, stroke, and multiple
organ failure (Coselli et al. 1999). However, other authors
including our group with solid practice abroad experi-
enced exceptionally disappointing results following the
principle of aggressive redo ascending/arch prosthetic
graft replacement, due to uncontrollable infective process
(Hargrove and Edmunds 1984; Nakajima et al. 1999). As a
result, many institutions switched during the last decades
to a more conservative, nonresectional, graft-sparing sur-
gical approach which appears to have become a method
of choice under certain circumstances (Coselli et al. 1990;
Coselli et al. 1999; Hargrove and Edmunds 1984; Nakajima
et al. 1999; LeMaire and Coselli 2007; Akowuah et al.
2007). We have reviewed 77 cases of any type of in situ
preservation for the treatment of infected ascending aortic
and/or aortic arch prosthetic grafts reported in the litera-
ture to date and found a collective early survival rate of
95% and a 100% success rate in terms of nonreccurrence
of graft infection (Coselli et al. 1990; Coselli et al. 1999;
Hargrove and Edmunds 1984; Nakajima et al. 1999;
LeMaire and Coselli 2007; Akowuah et al. 2007). These
excellent results are based on retrospective analyses of
surgical cohorts and case reports including patients with
ascending aortic grafts, many of whom also received an
arch graft, composite valve graft, or separate aortic valve
prosthesis (Coselli et al. 1990; Coselli et al. 1999; Hargrove
and Edmunds 1984; Nakajima et al. 1999; LeMaire and
Coselli 2007; Akowuah et al. 2007). In our case, graft-
sparing ascending aortic and aortic arch redo surgery
in the presence of an additional extranatomic aorto-
subclavian Dacron graft was performed in a patient with-
out prosthetic aortic valve endocarditis or prosthetic valve
dysfunction. The staged approach was a safe and effective
treatment strategy and preferable to conventional replace-
ment surgery as it is less invasive due to the avoidance of
the stress of an open replacement with anticoagulation for
cardiopulmonary bypass, thus lessening the risk for fatal
bleeding or uncontrollable sepsis. Furthermore, short-term
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entire infected spaces helps eradicate and sterilize the
complete operating field prior to omentum flap coverage
of the infected prosthetic graft (Nakajima et al. 1999).
Major advantages of omentum flap include the rich of
blood supply contributing to control the infection, suffi-
cient volume to fill the mediastinal cavity, aortic coverage,
and ease to perform (Coselli et al. 1990; Coselli et al. 1999;
Hargrove and Edmunds 1984; Nakajima et al. 1999;
LeMaire and Coselli 2007). Particularly with regard to
durability all the published cases have specifically docu-
mented the absence of recurrent graft infection after the
definitive in situ preservation procedure. Nearly all of
the reports included follow-up of at least two years. In
some cases nonreccurrence of graft infection has been
reported up to 10 years after such aortic redo procedures
(Nakajima et al. 1999).
Conclusions
Nonresectional, in situ graft-sparing surgical therapy is
safe and effective in patients with ascending and arch
prosthetic graft infection, as long as the infection is not
associated with native or prosthetic aortic valve endocardi-
tis or valve dysfunction, demonstrating superior outcomes
in comparison with traditional redo aortic replacement.
The recognition of this clinical issue has the potential to
spare patients unnecessary high-risk aortic redo operations.
However, there are no definitive treatment recommenda-
tions for ascending and arch prosthetic graft infection.
Clearly, more cases like this need to be reported and mon-
itored over time to support this conclusion.
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